Genomic Deletion of BAP1 and CDKN2A Are Useful Markers for Quality Control of Malignant Pleural Mesothelioma (MPM) Primary Cultures
Malignant pleural mesothelioma (MPM) is a deadly cancer that is caused by asbestos exposure and that has limited treatment options. The current standard of MPM diagnosis requires the testing of multiple immunohistochemical (IHC) markers on formalin-fixed paraffin-embedded tissue to differentiate MPM...
Main Authors: | Kadir Harun Sarun, Kenneth Lee, Marissa Williams, Casey Maree Wright, Candice Julie Clarke, Ngan Ching Cheng, Ken Takahashi, Yuen Yee Cheng |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-10-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/19/10/3056 |
Similar Items
-
LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer
by: Mahmood Faraz, et al.
Published: (2020-05-01) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
by: Astero Klampatsa, et al.
Published: (2017-09-01) -
From Normal to Obesity and Back: The Associations between Mitochondrial DNA Copy Number, Gender, and Body Mass Index
by: Daria Skuratovskaia, et al.
Published: (2019-05-01) -
Digital PCR as a tool to measure HIV persistence
by: Sofie Rutsaert, et al.
Published: (2018-01-01) -
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
by: Maria Pagano, et al.
Published: (2020-10-01)